Pfizer says additional analysis shows its vaccine is 95% effective in preventing COVID-19, seeking FDA authorization
UPDATED 7:05 PM PT – Wednesday, November 18, 2020
Pfizer officials have stated additional analysis from its experimental coronavirus vaccine suggested it’s more than 95 percent effective in preventing COVID-19.
On Wednesday, Pfizer and BioNTech released the updated data after initially estimating last week their vaccine was more than 90 percent effective.
— Pfizer Inc. (@pfizer) November 18, 2020
The drugmakers stated its effectiveness was consistent across all ages, races and ethnicities with no serious side effects. Additionally, BioNTech’s CEO plans to submit an emergency use authorization to the FDA within days.